Top menu
Main menu
Main Content
The Shmunis School of Biomedicine and Cancer Research
The George S. Wise
Faculty of Life Sciences
Tel Aviv University
Home
MyTAU
Student Portal
Library
עברית
Search
This site
Global search
Vision
Faculty
Research
Awarded Scholars
Graduate School
Post Doc
Research Facilities
Contact Us
Donated Equipment Aids in Urgent Coronavirus Research
Shmunis family gift ramps up the scientific capabilities of the School of Molecular Cell Biology and Biotechnology
Apr 6th, 2020
Donated Equipment Aids in Urgent Coronavirus Research
You are here
The Shmunis School of Biomedicine and Cancer Research
>
The Shmunis School of Biomedicine and Cancer Research
> News
Fields:
Select all
Life Sciences
Social Sciences
Categories:
Select all
Event
Events
Innovations
Award
Honors
NEWS
What are you interested in?
All topics
שיוך לתחומים (field_research_zone)
שיוך לתחומים (field_news_belong_area)
Life Sciences
Social Sciences
שיוך לתחומים חדש (field_belong_domains)
- Any -
Jan 20th, 2022
Dr. Aldema Sas-Chen won the Eclipse Award for Innovation in High Throughput
The award is granted by the RNA Society and is sponsored by Eclipse BioInnovations, a leading commercial genomics company based in San Diego, California
Jan 10th, 2022
Viruses and Game Theory
A new study from Tel Aviv University has found that, just like humans with Game Theory, viruses called bacteriophages (or phages) weigh all options and finally make an informed decision - whether the time has come to exit the dormant state and attack their bacterial host
Oct 20th, 2021
An Open Faculty Position: the Shmunis School of Biomedicine and Cancer Research
The Shmunis School of Biomedicine and Cancer Research seeks excellent candidates for a tenure-track faculty position. The position will start either in July or October 2022
Apr 18th, 2021
HSTalks with Prof. Isaac P. Witz - Now available for free watch
Watch Prof. Isaac Witz fascinating online lecture on the significance of the tumor microenvironment in cancer progression
Apr 11th, 2021
The COVID-19 vaccine is less effective against the South African variant
The study is the result of a collaboration between researchers at the Clalit Research Institute and Tel Aviv University - Prof. Adi Stern. At this stage, it is difficult to quantify the reduction in the vaccine's effectiveness against the South African variant. However, researchers estimate that this reduction is not extreme.
Mar 11th, 2021
Vaccinating breastfeeding mothers against COVID-19 may help protect their
According to a new study published by Dr. Yariv Wine and Ph.D Student Aya Kigel of the Shmunis School, joint with the Sourasky Medical Center, vaccinating breastfeeding mothers promotes the production of important antibodies in their breastmilk, potentially contributing to the protection of their nursing babies
Mar 10th, 2021
What's new at the Shmunis School for Biomedicine and Cancer Research?
Read all the latest news and keep track on February's publications
Jan 25th, 2021
Researches created a Chemical Pigment Rainbow
A new research sheds some new “colors” on melanin pigments. This research has been conducted by Dr. Ayala Lampel, of the Shmunis school of Biomedicine and Cancer Research and Prof. Rein V. Ulijn of The City University of New York (CUNY)
Oct 1st, 2020
Tilapia Lake Virus research is one of most impactful research projects granted
The US-Israel Binational Agricultural Research and Development Fund (BARD) has ranked the virology research conducted by Prof. Eran Bacharach (SBCR, TAU) and co-workers as one of the top impactful research projects that it funded over 40 years.
Sep 21st, 2020
Faculty Position
Faculty Position in the Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Israel
Apr 6th, 2020
Donated Equipment Aids in Urgent Coronavirus Research
Shmunis family gift ramps up the scientific capabilities of the School of Molecular Cell Biology and Biotechnology
Show More
Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing,
Contact us as soon as possible >>